Super Savings Fund (SSF)

KT-HEALTHCARE-SSF

KTAM World Healthcare Fund (Super Savings Fund)

16.6423
+-0.1389       +-0.8277%
*NAV
16.6424
Offer
16.6423
Bid
77,213,669.04
*Net Asset Value
*(According to the fund's currency)
  Data as of 02/12/2025
      Data as of 30/09/2025

Information

Fund type Open-end Equity Fund, Sector Fund, Feeder fund, Super Savings Fund (SSF)
Risk Level 7
Investment Policy The fund mainly only invests in the units of the retail fund Janus Henderson Global Life Sciences Fund (Master Fund), averaging no less than 80% of NAV during the accounting year.
Master Fund Janus Henderson Global Life Sciences Fund - Class H2
ISIN (Master Fund) IE00BFRSYJ83
Management Company
(Master Fund)		 Janus Henderson Capital Funds plc
Investment Policy
(Master Fund)		 The Janus Henderson Global Life Sciences Fund aims to achieve long-term capital growth by investing globally in equities of companies worldwide that is involved in life-sciences, providing healthcare or wellness.
Currency (Master Fund) USD
Hedging Policy (in THB) Subjected to the discretion of the fund manager to cope with the prevailing investment climate.
Dividend Policy Pay dividends
Minimum Subscription None
Minimum Redemption None
Trading Hours Every business day of the fund from 8.30 – 15.30 hrs
Krung Thai Bank and Selling Agents
Internet Trading: KTAM SMART TRADE (www.ktam.co.th)
Settlement Period T+4
Management Fee           Not exceeding 2.675% p.a.1 (Currently 1.07% p.a.1)
Trustee Fees Not exceeding 0.0749% p.a.1 (Currently 0.0321% p.a.1)
Registrar Fee Not exceeding 0.535% p.a.1 (Currently 0.214% p.a.1)
Front-end Fee Not exceeding 5.00%1  (Currently waived)
Back-end Fee Not exceeding 3.00%1  (Currently waived)
1 This rate include VAT, special business tax, and other similar taxes.

Portfolio information

Asset allocation proportions (Data as of 31/10/2025)
Securities with the highest investment value 5 First rank (Data as of 31/10/2025)
Securities Credit rating (% NAV)
Unit Trust Janus Global Life Sciences Fund N/A 98.35
Top 5 assets invested in the main fund (Data as of 31/10/2025)
  • Asset
    (% NAV)
  • Eli Lilly and Co
    8.67
  • Johnson & Johnson
    5.04
  • AstraZeneca PLC
    4.17
  • UnitedHealth Group Inc
    3.83
  • AbbVie Inc
    3.36
Master Fund Information as of 31/10/25
Investment allocation by industry group of the main fund (Data as of 31/10/2025)
  • Industry group
    (% NAV)
  • Healthcare
    100.00
Master Fund Information as of 31/10/25
Foreign investment allocation of the main fund (Data as of 31/10/2025)
  • Country
    (% NAV)
  • UNITED STATES
    85.31
  • UNITED KINGDOM
    4.23
  • SWITZERLAND
    3.90
  • FRANCE
    2.69
  • DENMARK
    1.57
Master Fund Information as of 31/10/25
Investment in other funds exceeding 20% (domestic and/or foreign funds) (Data as of 31/10/2025)
  • Fund Name : Unit Trust Janus Global Life Sciences Fund
    ISIN code : IE00BFRSYJ83
    Bloomberg code : JGLSUAU ID

Statistical information (Data as of 31/10/2025)
  • Maximum Drawdown
    -22.95 %
  • Recovering Period
    N/A
  • FX Hedging
    46.90 %
  • Portfolio Turnover Rate
    0.15
  • Sharpe Ratio
    0.12
  • Alpha
    -3.56
  • Beta
    0.58

© Copyright 2025 Morningstar Research Thailand. This information (1) is the property of Morningstar and/or its data providers, (2) reproduction or distribution is prohibited, and (3) Morningstar does not guarantee accuracy or completeness and is not responsible for any damages arising from its use. Past performance is not indicative of future results.

Note: Please read and refer to the prospectus summary for more detailed information.

Investors must understand the product features, return conditions, and risks before making an investment decision.

NAV of Fund

Performance results

Time period Past Performance (%)
( Ending on date 31 October 2025 ) 		Volatility (Standard Deviation) (% per year)
KT-HEALTHCARE-SSF Benchmark 1 Benchmark 2 KT-HEALTHCARE-SSF Benchmark 1 Benchmark 2
Year-to-date return 8.26 10.87 - 19.75 20.06 -
Last 3 months 16.70 17.62 - 15.60 15.52 -
Last 6 months 9.60 11.34 - 17.47 17.40 -
Last 1 year -1.46 1.56 - 19.24 19.52 -
Last 3 years - - - - - -
Last 5 years - - - - - -
Last 10 years - - - - - -
Since fund inception 2.45 6.01 - 15.89 17.24 -

* Peer Group Fund Performance Report by AIMC

Annual performance results

Year Past Performance (%) Volatility (Standard Deviation) (% per year)
KT-HEALTHCARE-SSF Benchmark 1 Benchmark 2 KT-HEALTHCARE-SSF Benchmark 1 Benchmark 2
2024 -1.63 -0.12 - 13.49 13.69 -
2023 0.35 9.26 - 14.34 18.10 -
2022 0.48 -1.85 - 17.76 15.43 -

* Peer Group Fund Performance Report by AIMC

Note :

  • The fund performance is prepared in accordance with AIMC standards no. สจก.ร. 1/2566 by
    1. Past performance less than 1 year is % for each period (not annualize)
    2. Past performance more than 1 year is % per year (annualize)
  • The assessment of the fund's performance as shown on this website has been in accordance with the assessment standards set by the Association of Investment Management Companies (AIMC).
  • Past performance of the fund may not be indicative of future operation.

Download document

Monthly Fund Update
เงื่อนไขการลงทุนและการถือครองเพื่อสิทธิประโยชน์ทางภาษี